Cerca un farmaco orfano
Altra/e opzione/i di ricerca
Autorizzazione all’immissione in commercio senza designazione orfana - Europa
- denominazione commerciale: SOMAVERT
- Codice ATC : H01AX01
- Numero EU: EU/1/02/240/...
- AIC data : 13/11/2002
- Titolare dell'AIC: PFIZER LIMITED
- Relazione di Valutazione Pubblica Europea (EPAR)
Treatment of patients with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalize IGF-I concentrations or was not tolerate.
This product is no longer an orphan medicine. It was originally designated an orphan medicine on 14 February 2001. Somavert was withdrawn from the Community register of orphan medicinal products in November 2012 at the end of the period of market exclusivity.